These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38830763)

  • 1. Norepinephrine Drives Sleep Fragmentation Activation of Asparagine Endopeptidase, Locus Ceruleus Degeneration, and Hippocampal Amyloid-β
    Zhang K; Zhu Y; Fenik P; Fleysh D; Ly C; Thomas SA; Veasey S
    J Neurosci; 2024 Jul; 44(28):. PubMed ID: 38830763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice.
    Zhu Y; Zhan G; Fenik P; Brandes M; Bell P; Francois N; Shulman K; Veasey S
    J Neurosci; 2018 Nov; 38(48):10255-10270. PubMed ID: 30322903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of endogenous amyloid-β to the coeruleo-cortical pathway: consequences of noradrenergic depletion.
    Ross JA; Reyes BAS; Thomas SA; Van Bockstaele EJ
    Brain Struct Funct; 2018 Jan; 223(1):267-284. PubMed ID: 28779307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of neuroinflammation, microglial activation, and degeneration of the locus coeruleus-norepinephrine system in APP/PS1 and aging mice.
    Cao S; Fisher DW; Rodriguez G; Yu T; Dong H
    J Neuroinflammation; 2021 Jan; 18(1):10. PubMed ID: 33407625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal cord injury-activated C/EBPβ-AEP axis mediates cognitive impairment through APP C586/Tau N368 fragments spreading.
    Wu Z; Zhu R; Yu Y; Wang J; Hu X; Xu W; Ren Y; Li C; Zeng Z; Ma B; Xie N; Lin G; Ma B; Zhu R; Ye K; Cheng L
    Prog Neurobiol; 2023 Aug; 227():102467. PubMed ID: 37257680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis.
    Stein TD; Anders NJ; DeCarli C; Chan SL; Mattson MP; Johnson JA
    J Neurosci; 2004 Sep; 24(35):7707-17. PubMed ID: 15342738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocretin/orexin influences chronic sleep disruption injury in the hippocampus.
    Nick H; Fenik P; Zhu Y; Veasey S
    Front Aging Neurosci; 2022; 14():1025402. PubMed ID: 36275002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-in-life neurodegeneration after chronic sleep loss in young adult mice.
    Owen JE; Zhu Y; Fenik P; Zhan G; Bell P; Liu C; Veasey S
    Sleep; 2021 Aug; 44(8):. PubMed ID: 33768250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model.
    Mi X; Du H; Guo X; Wu Y; Shen L; Luo Y; Wang D; Su Q; Xiang R; Yue S; Wu S; Gong J; Yang Z; Zhang Y; Tan X
    Acta Biomater; 2022 Mar; 141():388-397. PubMed ID: 35045359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.
    Kang SS; Liu X; Ahn EH; Xiang J; Manfredsson FP; Yang X; Luo HR; Liles LC; Weinshenker D; Ye K
    J Clin Invest; 2020 Jan; 130(1):422-437. PubMed ID: 31793911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
    Heneka MT; Nadrigny F; Regen T; Martinez-Hernandez A; Dumitrescu-Ozimek L; Terwel D; Jardanhazi-Kurutz D; Walter J; Kirchhoff F; Hanisch UK; Kummer MP
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6058-63. PubMed ID: 20231476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models.
    Ikezu S; Ingraham Dixie KL; Koro L; Watanabe T; Kaibuchi K; Ikezu T
    Acta Neuropathol Commun; 2020 Feb; 8(1):12. PubMed ID: 32019603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.
    Taylor TN; Alter SP; Wang M; Goldstein DS; Miller GW
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):97-105. PubMed ID: 24025942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.
    Zhang Z; Song M; Liu X; Su Kang S; Duong DM; Seyfried NT; Cao X; Cheng L; Sun YE; Ping Yu S; Jia J; Levey AI; Ye K
    Nat Commun; 2015 Nov; 6():8762. PubMed ID: 26549211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease.
    Kang SS; Ahn EH; Liu X; Bryson M; Miller GW; Weinshenker D; Ye K
    Acta Neuropathol; 2021 Jul; 142(1):139-158. PubMed ID: 33895869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
    Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG
    J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
    Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
    eNeuro; 2017; 4(2):. PubMed ID: 28374012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.